NEXUS Arch: A Multicenter Study Evaluating the Initial Experience With a Novel Aortic Arch Stent Graft System
David Planer(Hadassah Medical Center), Mário Lachat(Metallco (Norway)), Gabby Elbaz‐Greener(Hadassah Medical Center), Yaniv Marmur, Matteo Orrico(Azienda Ospedaliera San Camillo-Forlanini), Augusto D’Onofrio(University of Padua), Michele Antonello(University of Padua), Andrew Hill(Trans Tasman Radiation Oncology Group), Felice Pecoraro(University of Palermo), Andrew Holden(University of Auckland), Lyubov Chaykovska(Klinik Hirslanden), Nicola Mangialardi(Azienda Ospedaliera San Camillo-Forlanini), Hubert Schelzig(Düsseldorf University Hospital), Sonia Ronchey(Ospedale San Filippo Neri), Kong T. Tan(Toronto General Hospital), Thomas F. Lindsay(Toronto General Hospital)
Cited by 75
Related Papers
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
|The Lancet Oncology|2017|2.8k
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair–Deficient/Microsatellite Instability–High Metastatic Colorectal Cancer
|Journal of Clinical Oncology|2018|2.1k
Editor's Choice – Management of Descending Thoracic Aorta Diseases
|European Journal of Vascular and Endovascular Surgery|2017|1.2k
Editor's Choice -- European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Asymptomatic Lower Limb Peripheral Arterial Disease and Intermittent Claudication
|European Journal of Vascular and Endovascular Surgery|2023|419